N. Akar et al., Effect of metylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients, THROMB RES, 97(3), 2000, pp. 163-167
Possible effect of three common mutations in (MTHFR 677 C-T; 1317 T-C; 1298
C-A:) and FV 1691 G-A mutation was studied in Turkish patients with thromb
osis and compared with normal controls. The case-control study included 68
patients with the diagnosis of deep vein thrombosis and 66 controls, consec
utively selected among subjects without personal and familial history of at
herothrombosis. Patients with deep vein thrombosis were selected if Doppler
ultrasonography was positive. Only, the comparision of factor V 1691 G-A m
utation revealed statistically significant difference in control (6.06%) an
d deep vein thrombosis (23.5%) group. Risk assessment of double prothrombot
ic gene alterations revealed only FV 1691 G-A mutation as an independent ri
sk factor for thrombosis (odds ratio 4.7 [1.5-15.0]), but our data suggeste
d that MTHFR 677 has effect on its own (odds ratio 1.97 [0.6-2.7]) but may
have synergy with FV 1691 G-A (odds ratio 8.12 [2.0-25.3]). However, MTHFR
1298 A-C and 1317 T-C does not have any effect; furthermore, being heterozy
gote at two different loci or homozygosity at least in a locus for 677 and
1298 revealed a significant increase (odds ratio 9 and 24 [1.3-59.3 and 2.3
-240.3]) between these two groups. (C) 2000 Elsevier Science Ltd. All right
s reserved.